Ptc Therapeutics (PTCT) Treasury Shares (2013 - 2026)

Ptc Therapeutics' Treasury Shares history runs 14 years deep, the most recent figure standing at $165625.0 for Q1 2026.

• In Q1 2026, Treasury Shares fell 95.72% year-over-year to $165625.0; the TTM figure through Mar 2026 stood at $165625.0 (down 95.72% YoY), while the FY2025 annual figure was $3.7 million, up 1678.0% from the prior year.
• Treasury Shares was $165625.0 for Q1 2026 at Ptc Therapeutics, down from $3.7 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.9 million in Q1 2025 to a low of $165625.0 in Q1 2026.
• Historically, Treasury Shares has averaged $2.9 million across 5 years, with a median of $3.6 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Treasury Shares surged 1678.0% in 2025, then sank 95.72% in 2026.
• A 5-year view of Treasury Shares shows it stood at $2.5 million in 2022, then climbed by 13.91% to $2.9 million in 2023, then sank by 92.8% to $206250.0 in 2024, then soared by 1678.0% to $3.7 million in 2025, then sank by 95.48% to $165625.0 in 2026.
• The last three Treasury Shares figures came in at $165625.0 (Q1 2026), $3.7 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.